Page last updated: 2024-10-20

pyruvic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

pyruvic acid has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies

Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.

Research Excerpts

ExcerptRelevanceReference
" CB-839 is a potent, selective, orally bioavailable inhibitor of glutaminase that has activity in Triple receptor-Negative Breast Cancer (TNBC) cell lines and evidence of efficacy in advanced TNBC patients."1.56Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer. ( Baguley, BC; Dechaume, AL; Katt, WP; Leung, EY; Murray, PM; Singleton, DC, 2020)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Singleton, DC1
Dechaume, AL1
Murray, PM1
Katt, WP1
Baguley, BC1
Leung, EY1
Vande Voorde, J1
Ackermann, T1
Pfetzer, N1
Sumpton, D1
Mackay, G1
Kalna, G1
Nixon, C1
Blyth, K1
Gottlieb, E1
Tardito, S1
Bizjak, M1
Malavašič, P1
Pirkmajer, S1
Pavlin, M1

Other Studies

3 other studies available for pyruvic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer.
    BMC cancer, 2020, May-25, Volume: 20, Issue:1

    Topics: Benzeneacetamides; Cell Proliferation; Drug Resistance, Neoplasm; Female; Glutaminase; Glutamine; Hu

2020
Improving the metabolic fidelity of cancer models with a physiological cell culture medium.
    Science advances, 2019, Volume: 5, Issue:1

    Topics: Arginine; Argininosuccinate Lyase; Cell Line, Tumor; Cell Proliferation; Culture Media; Female; Ferr

2019
Comparison of the effects of metformin on MDA-MB-231 breast cancer cells in a monolayer culture and in tumor spheroids as a function of nutrient concentrations.
    Biochemical and biophysical research communications, 2019, 07-23, Volume: 515, Issue:2

    Topics: AMP-Activated Protein Kinases; Cell Culture Techniques; Cell Survival; Enzyme Activation; Female; Gl

2019